Stock Price Quote

SEQUENT SCIENTIFIC LTD.

NSE : SEQUENTBSE : 512529ISIN CODE : INE807F01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE80.95-9.2 (-10.21 %)
PREV CLOSE ( ) 90.15
OPEN PRICE ( ) 87.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 89587
TODAY'S LOW / HIGH ( )79.80 88.75
52 WK LOW / HIGH ( )62.9 99.35
NSE80.70-9.3 (-10.33 %)
PREV CLOSE( ) 90.00
OPEN PRICE ( ) 88.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 80.70 (22409)
VOLUME 458458
TODAY'S LOW / HIGH( ) 79.00 88.95
52 WK LOW / HIGH ( )62.8 99.25
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-06 1985
Management Info
Gopakumar G Nair - Chairman Manish Gupta - Managing Director
Registered Office

Address 301, 'dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. Estate, Thane (W) ,
Thane,
Maharashtra-400604

Phone

Email pidsecretarial@yahoo.co.in

Website http://www.sequent.in/

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

05Feb Sequent Scientific informs about discl
Sequent Scientific has informed that the exchange has received disclosur..
03Feb Sequent Scientific inaugurates new sta
Sequent Scientific has inaugurated a new state-of-the-art multifaceted a..
16Jan Board Meeting Intimation for Approval
SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of..
27Dec Sequent Scientific informs about discl
Sequent Scientific has informed about disclosure under Regulation 31(1)..
26Dec Sequent Scientific informs about discl
Sequent Scientific has informed about disclosure under Regulation 31(1)..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit29.190000000000175.86
Gross Profit 46.9300000000001 62.03
Operating Profit 80.7800000000001166.87
Net Sales 617.991676.77

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4200.45 (1.02%)
M.Cap ( in Cr)19216.11
Procter&Gamble Healt (BSE)
peergroup  4179.90 (0.33%)
M.Cap ( in Cr)6938.38
Ipca Laboratories (BSE)
peergroup  1361.70 (0.80%)
M.Cap ( in Cr)17205.37
Eris Lifesciences (BSE)
peergroup  433.60 (2.48%)
M.Cap ( in Cr)5887.45
Shree Ganesh Remed. (BSE)
peergroup  108.45 (7.80%)
M.Cap ( in Cr)97.29

Shareholding Pattern

PROMOTERS 56.15%
NON-INSTITUTION 32.88%
MUTUAL FUNDS/UTI 3.79%
FI/BANKS/INSURANCE 0.42%
GOVERNMENT 0%
FII 0%

About Sequent Scientific Ltd.

Sequent Scientific Ltd. was incorporated in the year 1985. Its today's share price is 80.95. Its current market capitalisation stands at Rs 2010.56 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10393.07 Cr and Total Income of Rs.10479.79 Cr. The company's management includes K E C Raja Kumar, S Devendra, Narendra Mairpady, Kausalya Santhanam, Sharat Narasapur, Manish Gupta, Gopakumar G Nair.

It is listed on the BSE with a BSE Code of 512529 , NSE with an NSE Symbol of SEQUENT and ISIN of INE807F01027. It's Registered office is at 301, 'dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. Estate, Thane (W) Thane-400604, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells, Deloittee Haskins & Sells

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X